Journal of Peking University(Health Sciences) ›› 2018, Vol. 50 ›› Issue (6): 949-951. doi: 10.19723/j.issn.1671-167X.2018.06.001
• Article • Next Articles
CLC Number:
| [1] |
Bohan A, Peter JB . Polymyositis and dermatomyositis (first of two parts)[J]. N Engl J Med, 1975,292(7):344-347.
doi: 10.1056/NEJM197502132920706 |
| [2] |
Bohan A, Peter JB . Polymyositis and dermatomyositis (second of two parts)[J]. N Engl J Med, 1975,292(8):403-407.
doi: 10.1056/NEJM197502202920807 |
| [3] |
Venalis P, Lundberg IE . Immune mechanisms in polymyositis and derrnatomyositis and potential targets for therapy[J]. Rheumatology (Oxford), 2014,53(3):397-405.
doi: 10.1093/rheumatology/ket279 pmid: 23970542 |
| [4] |
Dalakas MC . Inflammatory muscle diseases[J]. N Engl J Med, 2015,372(18):1734-1747.
doi: 10.1056/NEJMra1402225 |
| [5] |
Lu X, Peng Q, Wang G . Discovery of new biomarkers of idiopathic inflammatory myopathy[J]. Clin Chim Acta, 2015,444:117-125.
doi: 10.1016/j.cca.2015.02.007 pmid: 25681646 |
| [6] |
Dalakas M . Polymyositis, dermatomyositis, and inclusion-body myositis[J]. N Engl J Med, 1991,325(21):1487-1498.
doi: 10.1056/NEJM199111213252107 pmid: 1658649 |
| [7] |
Tanimoto K, Nakano K, Kano S , et al. Classification criteria for polymyositis and dermatomyositis[J]. J Rheumatol, 1995,22(4):668-674.
doi: 10.1002/art.1780380424 pmid: 7791161 |
| [8] |
Targoff I, Miller F, Medsger T , et al. Classification criteria for the idiopathic inflammatory myopathies[J]. Curr Opin Rheumatol, 1997,9(6):527-535.
doi: 10.1097/00002281-199711000-00008 pmid: 9375282 |
| [9] |
Dalakas MC, Hohlfeld R . Polymyositis and dermatomyositis[J]. Lancet, 2003,362(9388):971-982.
doi: 10.1016/S0140-6736(03)14368-1 |
| [10] |
Hoogendijk JE, Amato AA, Lecky BR , et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands[J]. Neuromuscul Disord, 2004,14(5):337-345.
doi: 10.1016/j.nmd.2004.02.006 pmid: 15099594 |
| [11] |
DeBleecker JL, Lundberg IE, De Visser M . 193rd ENMC Myositis Muscle Biopsy Study Group. 193rd ENMC International Workshop Pathology Diagnosis of Idiopathic Inflammatory Myopathies 30 November-2 December 2012, Naarden, the Netherlands[J]. Neuromuscul Disord, 2013,23(11):945-951.
doi: 10.1016/j.nmd.2013.07.007 pmid: 24011698 |
| [12] |
DeBleecker JL, De Paepe B, Aronica E , et al. 205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies Part Ⅱ 28-30 March 2014, Naarden, The Netherlands[J]. Neuromuscul Disord, 2015,25(3):268-272.
doi: 10.1016/j.nmd.2014.12.001 pmid: 25572016 |
| [13] |
De Bleecker JL, Vervaet V , Van den Bergh P. Necrotizing myopathy with microvascular deposition of the complement membrane attack complex[J]. Clin Neuropathol, 2004,23(2):76-79.
doi: 10.1016/j.clineuro.2003.12.001 pmid: 15074581 |
| [14] |
Takada T, Hirakata M, Suwa A , et al. Clinical and histopathological features of myopathies in Japanese patients with anti-SRP autoantibodies[J]. Mod Rheumatol, 2009,19(2):156-164.
doi: 10.3109/s10165-008-0139-8 |
| [15] |
Christopher-Stine L, Casciola-Rosen LA, Hong G , et al. A novel autoantibody recognizing 200-kD and 100-kD proteins is associated with an immune-mediated necrotizing myopathy[J]. Arthritis Rheum, 2010,62(9):2757-2766.
doi: 10.1002/art.27572 pmid: 3026777 |
| [16] |
Ge Y, Lu X, Peng Q , et al. Clinical characteristics of anti-3-hydroxy-3-methylglutaryl coenzyme a reductase antibodies in Chinese patients with idiopathic inflammatory myopathies[J]. PLoS One, 2015,10(10):e0141616.
doi: 10.1371/journal.pone.0141616 pmid: 4624805 |
| [17] |
Allenbach Y , DrouotL, RigoletA, et al. Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin[J]. Medicine (Baltimore), 2014,93(3):150-157.
doi: 10.1097/MD.0000000000000028 |
| [18] |
Wang L, Liu L, Hao H , et al. Myopathy with anti-signal recognition particle antibodies: clinical and histopathological features in Chinese patients[J]. Neuromuscul Disord, 2014,24(4):335-341.
doi: 10.1016/j.nmd.2014.01.002 pmid: 24491486 |
| [19] |
Allenbach Y, Mammen AL, Benveniste O , et al. 224th ENMC International Workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies, The Netherlands, 14-16 October 2016[J]. Neuromuscul Disord, 2018,28(1):87-99.
doi: 10.1016/j.nmd.2017.09.016 |
| [20] |
Van der Meulen MF, Bronner M, Hoogendijk JE , et al. Polymyositis: a diagnostic entity reconsidered[J]. Neurology, 2003,61(3):316-321.
doi: 10.1212/WNL.61.3.316 |
| [21] |
Kishi T, Rider LG, Pak K , et al. Association of anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase autoantibodies with DRB1 *07:01 and severe myositis in juvenile myositis patients [J]. Arthritis Care Res (Hoboken), 2017,69(7):1088-1094.
doi: 10.1002/acr.v69.7 |
| [22] |
Lundberg IE, Tjärnlund A, Bottai M , et al. European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups[J]. Arthritis Rheumatol, 2017,69(12):2271-2282.
doi: 10.1002/art.40320 |
| [1] | Jiayi TIAN, Yixue GUO, Xia ZHANG, Xiaolin SUN, Jing HE. Flow cytometry analysis of normal range of natural killer cells and their subsets in peripheral blood of healthy Chinese adults [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 839-844. |
| [2] | Yushu YANG, Xuan QI, Meng DING, Wei WANG, Huifang GUO, Lixia GAO. Diagnostic values of anti-salivary gland protein-1 antibody combined with anti-parotid secretory protein antibody for Sjögren's syndrome [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 845-852. |
| [3] | Hua ZHONG, Yuan LI, Liling XU, Mingxin BAI, Yin SU. Application of 18F-FDG PET/CT in rheumatic diseases [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 853-859. |
| [4] | Zhihui WU, Mingzhi HU, Qiaoying ZHAO, Fengfeng LV, Jingying ZHANG, Wei ZHANG, Yongfu WANG, Xiaolin SUN, Hui WANG. Immunomodulatory mechanism of umbilical cord mesenchymal stem cells modified by miR-125b-5p in systemic lupus erythematosus [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 860-867. |
| [5] | Dongwu LIU, Jie CHEN, Mingli GAO, Jing YU. Rheumatoid arthritis with Castleman-like histopathology in lymph nodes: A case report [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 928-931. |
| [6] | Zhengfang LI,Cainan LUO,Lijun WU,Xue WU,Xinyan MENG,Xiaomei CHEN,Yamei SHI,Yan ZHONG. Application value of anti-carbamylated protein antibody in the diagnosis of rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 729-734. |
| [7] | 佳佳 乔,聪 田,晓波 黄,军 刘. [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 745-749. |
| [8] | Huina HUANG,Jing ZHAO,Xiangge ZHAO,Ziran BAI,Xia LI,Guan WANG. Regulatory effect of lactate on peripheral blood CD4+ T cell subsets in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(3): 519-525. |
| [9] | Limin REN,Chuchu ZHAO,Yi ZHAO,Huiqiong ZHOU,Liyun ZHANG,Youlian WANG,Lingxun SHEN,Wenqiang FAN,Yang LI,Xiaomei LI,Jibo WANG,Yongjing CHENG,Jiajing PENG,Xiaozhen ZHAO,Miao SHAO,Ru Li. Low disease activity and remission status of systemic lupus erythematosus in a real-world study [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 273-278. |
| [10] | Xiaofei TANG,Yonghong LI,Qiuling DING,Zhuo SUN,Yang ZHANG,Yumei WANG,Meiyi TIAN,Jian LIU. Incidence and risk factors of deep vein thrombosis in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 279-283. |
| [11] | Zhanhong LAI,Jiachen LI,Zelin YUN,Yonggang ZHANG,Hao ZHANG,Xiaoyan XING,Miao SHAO,Yuebo JIN,Naidi WANG,Yimin LI,Yuhui LI,Zhanguo LI. A unicenter real-world study of the correlation factors for complete clinical response in idiopathic inflammatory myopathies [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 284-292. |
| [12] | Yi-jun HAN,Chang-hong LI,Xiu-ying CHEN,Jin-xia ZHAO. Comparison of clinical and immunological characteristics between primary Sjögren's syndrome patients with positive and negative anti-SSB antibody [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1000-1006. |
| [13] | Jian-bin LI,Meng-na LYU,Qiang CHI,Yi-lin PENG,Peng-cheng LIU,Rui WU. Early prediction of severe COVID-19 in patients with Sjögren’s syndrome [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1007-1012. |
| [14] | Xue ZOU,Xiao-juan BAI,Li-qing ZHANG. Effectiveness of tofacitinib combined with iguratimod in the treatment of difficult-to-treat moderate-to-severe rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1013-1021. |
| [15] | Wen-gen LI,Xiao-dong GU,Rui-qiang WENG,Su-dong LIU,Chao CHEN. Expression and clinical significance of plasma exosomal miR-34-5p and miR-142-3p in systemic sclerosis [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1022-1027. |
|
||